Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity - Wikidata - awgldk - TriplyDB

Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity

Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity

http://www.wikidata.org/entity/Q35198511

about

Diabetic complications in obese type 2 diabetic rat models Lifestyle modifications and erectile dysfunction: what can be expected?Sex differences in the physiology of eating Endogenous sex hormones, metabolic syndrome, and diabetes in men and women Insulin and Leptin Signaling Interact in the Mouse Kiss1 Neuron during the Peripubertal Period.Leptin level and oxidative stress contribute to obesity-induced low testosterone in murine testicular tissue.Causal relationship between obesity and serum testosterone status in men: A bi-directional mendelian randomization analysis Chronic rapamycin treatment causes diabetes in male mice Thyroid hormone and leptin in the testis.Effects of Hydro-Alcoholic Extract of Rhus coriaria (Sumac) Seeds on Reproductive Complications of Nicotinamide-Streptozotocin Induced Type-2 Diabetes in Male Mice Testosterone level in men with type 2 diabetes mellitus and related metabolic effects: A review of current evidence.Mechanisms linking obesity to male infertility.Androgen Deficiency and Erectile Dysfunction in Patients with Type 2 Diabetes.Testosterone concentration and insulin sensitivity in young men with type 1 and type 2 diabetes.The Interactions between Insulin and Androgens in Progression to Castrate-Resistant Prostate Cancer No effects of n-3 fatty acid supplementation on serum total testosterone levels in older men: the Alpha Omega Trial Insulin Resistance and Inflammation in Hypogonadotropic Hypogonadism and Their Reduction After Testosterone Replacement in Men With Type 2 Diabetes Testosterone concentrations in young pubertal and post-pubertal obese males.Clomiphene Citrate Effectively Increases Testosterone in Obese, Young, Hypogonadal Men The Association between Androgenic Hormone Levels and the Risk of Developing Coronary Artery Disease (CAD).Follicle-stimulating hormone associates with prediabetes and diabetes in postmenopausal women.Independent effects of testosterone on lipid oxidation and VLDL-TG production: a randomized, double-blind, placebo-controlled, crossover study.The prevalence of hypogonadism in diabetic men in Isfahan Endocrine and Metabolism Research Center, Isfahan, Iran.Strength training and testosterone treatment have opposing effects on migration inhibitor factor levels in ageing men.Negative effects of high glucose exposure in human gonadotropin-releasing hormone neurons.Diabetes and sexual dysfunction: current perspectives.Prevalence of low testosterone levels in men with type 2 diabetes mellitus: a cross-sectional study.The role of obesity and type 2 diabetes mellitus in the development of male obesity-associated secondary hypogonadism.Osteoporosis in men: recent progress.Prevalence, Pathophysiology, and Management of Androgen Deficiency in Men with Metabolic Syndrome, Type 2 Diabetes Mellitus, or Both.Osteoporosis in patients with diabetes after kidney transplantation.Non-menopausal endocrine and non-endocrine causes of flushing and sweating.Serum Total Testosterone Concentrations in the US Household Population from the NHANES 2011-2012 Study Population.Analysis of relationships between the concentrations of total testosterone and dehydroepiandrosterone sulfate and the occurrence of selected metabolic disorders in aging men.Remission of type 2 diabetes in a hypogonadal man under long-term testosterone therapy.Clomiphene citrate effect in obese men with low serum testosterone treated with metformin due to dysmetabolic disorders: A randomized, double-blind, placebo-controlled study.The incidence of hypogonadotropic hypogonadism in type 2 diabetic men in Polish population Assessment of Hypogonadism in Men With Type 2 Diabetes: A Cross-Sectional Study From Saudi Arabia.Effect of testosterone on hepcidin, ferroportin, ferritin and iron binding capacity in patients with hypogonadotropic hypogonadism and type 2 diabetes.An idiopathic hypogonadotropic hypogonadism patient with metabolic disorder and diabetes: case report.

P2860

Q26830284-33E5360A-F179-4931-B6A6-EEAC80631F8D Q26866570-C4D1C757-11B9-4D63-8E61-EACA67837F38 Q27007513-D52D4730-B177-4306-B834-007E6DD19339 Q27023901-D5730356-413C-4084-81D1-659A806044AE Q30405254-D5BA0CBD-84E2-4A43-A59E-A679E4C9AAA3 Q33563375-293834B6-25AD-4AF5-A7A0-DA2A0913A4FB Q33610868-E8DBEB90-D762-4736-AE96-DA15B9B6F622 Q34062932-78583591-73AB-4793-A8BD-31877FEF76FF Q34569982-0D001BC4-E719-45AE-B093-E01A3754B716 Q34984100-CD53C7CF-6484-4B23-9BA2-3E5507A966EB Q35192163-ACCE005D-2124-4578-A9B6-A8412BF0D25B Q35533819-07A0FA17-840F-4E83-81D3-B43CCE111468 Q35871552-1B7A8028-6846-4A47-B751-C5833F920D6B Q35876203-511C91B5-5F03-46A4-B4C3-C0B8902E8519 Q35882782-706ECCE7-D640-4667-AFD2-5EC03C61285A Q36069395-0313DD0B-1E52-4BDA-BC36-C3612DE04015 Q36392574-6FBDB544-965F-45B3-8BC4-3978F7EA2235 Q36472816-4AB8CD4E-08A3-4EA1-A4B4-44AD5AD06E6D Q36525484-7DA3C4C0-93FC-40B9-BCCC-90886BBE2BD6 Q36769757-08CB794A-3E08-4818-881C-DC74ED6DB3DF Q36783058-1EF12AB0-81EB-448C-A5B1-DB60F6F9A74C Q36796043-DEB38156-5505-482D-8984-660D354D1DCD Q36938069-D257C061-C359-44A1-9291-BDB6BD846A19 Q37194827-E8CF1C52-6015-400D-A757-A5757F27B968 Q37486480-582EBCD7-88C1-47C6-BBDD-AEA53B541675 Q37630425-DD8AF616-2BB4-4C79-91EC-9D2A55B2A38F Q37642529-987BB3C4-6D1A-4741-A329-921C75276F24 Q38057355-93E93D20-255A-4E19-913C-AFA667D81481 Q38077109-96BDE677-1706-4D86-8695-C094E77959FD Q38569696-8E1CF3FE-557E-4057-A165-EED7B95E762C Q39014553-16C30848-1EE5-42B4-9BBE-D93F9A004EFD Q39398103-829C4C2D-276F-4565-B853-B2F23AC303BA Q40382819-922AE8C7-93BC-4A2A-B4BA-0871294D67A1 Q41352741-60D09116-E75F-4EA7-B390-AE209AA5CC3A Q41405214-6FB83574-C3E5-4465-9078-C5F5BFC082A7 Q41501337-3AF6BFBA-D9D8-430E-8D2C-0B8ECB3C1D1A Q42114446-E0CE17CA-2E01-4C87-8962-DFA824221974 Q42252900-C40F1972-7FCA-441D-A240-CE6D3390A3B3 Q42494574-2E3522B9-A390-41A7-A788-D3C6783C1201 Q43167131-D0924516-5E5F-424C-83C7-2AD96682FC25

P2860

Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity

http://www.wikidata.org/entity/Q35198511

description

2011 nî lūn-bûn

@nan

2011 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած

@hyw

2011 թվականի սեպտեմբերին հրատարակված գիտական հոդված

@hy

2011年の論文

@ja

2011年論文

@yue

2011年論文

@zh-hant

2011年論文

@zh-hk

2011年論文

@zh-mo

2011年論文

@zh-tw

2011年论文

@wuu

name

Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity

@ast

Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity

@en

type

label

Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity

@ast

Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity

@en

prefLabel

Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity

@ast

Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity

@en

P1433

Q35198511-7D843964-8314-4FC3-B562-688CCC8082F7

P1476

Q35198511-1280076A-518D-4221-899C-01E36FABE868

P2093

Q35198511-9AC25A04-DDBA-45ED-B63B-CE2AF82836DA

Q35198511-EDE84B9F-28C9-4D07-9534-62552A5E67F0

P2860

Q35198511-02E60DCD-155E-4BDC-8DB3-F2FB08E8CEC7

Q35198511-04330CFB-926E-42D7-88DB-D6848B6A2ABA

Q35198511-04CAA8F4-D0CA-4F46-B24D-E35241B009ED

Q35198511-0C1FD7CC-03C5-42DE-94EF-0C0651EEDCB4

Q35198511-12DE858C-E770-4544-8A9C-58D48D8B005B

Q35198511-18D344F5-0E14-4D7B-8582-F526BE8B0300

Q35198511-19EA7C0B-6918-40BA-BCCA-EAA797022969

Q35198511-24159167-EDBD-4D13-AF87-D18DE54418E8

Q35198511-286E11B3-AB3F-4D1F-8971-989B9276C3E2

Q35198511-2AD41CD8-610D-4613-91E7-82D072A517C0

P304

Q35198511-86002CC4-E664-4015-B9DD-012FB09198B0

P31

Q35198511-25668FA6-F0CC-4090-9478-6F2FC1A5860C

P356

Q35198511-F46817DD-0A61-426B-9ADA-3642ABC644A2

P407

Q35198511-6BA75864-76B7-42A9-8914-430E5808061C

P433

Q35198511-6200CE88-1E7C-4480-92CC-365F9731BCAB

P478

Q35198511-1FF00F6C-E239-42FF-9863-B992306F3CDD

P577

Q35198511-B2177958-9B4A-4E7B-B49B-613C7905DA86

P5875

Q35198511-6AB71850-BC74-4B94-91B1-75BC9EC67FBF

P698

Q35198511-77AC62D5-505B-430D-A486-28DA373F072C

P921

Q35198511-1F579164-30D4-4456-9645-FCF1EEC68FF8

Q35198511-61055F5C-B98C-4BAA-9B77-A6889B4D4EB6

Q35198511-7D166A9F-6225-45BE-9744-E02146FA0115

P932

Q35198511-BEAE2C5A-B686-4FF6-B972-1927765B12BA

P356

P1433

The Journal of Clinical Endocrinology and Metabolism

P1476

Update: Hypogonadotropic hypogonadism in type 2 diabetes and obesity

@en

P2093

Paresh Dandona

http://www.w3.org/2001/XMLSchema#string

Sandeep Dhindsa

http://www.w3.org/2001/XMLSchema#string

P2860

Adverse Effects of Testosterone Therapy in Adult Men: A Systematic Review and Meta-Analysis

Adverse events associated with testosterone administration

Sex hormone-binding globulin and risk of type 2 diabetes in women and men

Effect of long-acting testosterone treatment on functional exercise capacity, skeletal muscle performance, insulin resistance, and baroreflex sensitivity in elderly patients with chronic heart failure a double-blind, placebo-controlled, randomized s

Serum testosterone and sex hormone-binding globulin concentrations and the risk of prostate carcinoma: a longitudinal study

Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden.

A predominant role for parenchymal c-Jun amino terminal kinase (JNK) in the regulation of systemic insulin sensitivity.

Genetic evidence that raised sex hormone binding globulin (SHBG) levels reduce the risk of type 2 diabetes

Sex hormone-binding globulin as an independent predictor of incident type 2 diabetes mellitus in men

Testosterone concentrations in diabetic and nondiabetic obese men.

P304

2643-2651

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1210/JC.2010-2724

http://www.w3.org/2001/XMLSchema#string

P407

P433

9

http://www.w3.org/2001/XMLSchema#string

P478

96

http://www.w3.org/2001/XMLSchema#string

P577

2011-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

51624209

http://www.w3.org/2001/XMLSchema#string

P698

21896895

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

3167667

http://www.w3.org/2001/XMLSchema#string